As CEO, Sherri creates the Medigram vision, defines priorities, and aligns resources to meet the organization’s goals. Before being promoted to CEO in December 2014, Sherri led the Sales, Marketing, and fundraising strategy. Prior to working at Medigram, Sherri owned a healthcare technology consulting practice. Previously, she was a Senior Sales Executive at Johnson & Johnson with over nine years of experience in more than a dozen disease states; there she won numerous awards, trained others, and participated in the management development program. Sherri serves on the Board of Directors for HIMSS Northern California as Co-Chair for the Innovation conference and contributes to the newsletter; She demonstrates her passion for improving healthcare by championing the 2016-2017 series on data strategy & governance to support the chapter’s membership growth as leaders of data-driven organizations. Sherri is an advisory board member for the National Bundled Payment Collaborative and a member of Santa Clara University’s Board of Fellows. She earned her BS degree in Combined Sciences from Santa Clara University and has held series 7 and series 66 investment-banking licenses. Sherri recharges while exercising, reading, writing, learning to code, and by spending time with her husband and their friends cooking, hiking, skiing, and learning together.
Chris McCarthy, Director of Innovation Learning, Kaiser Permanente's Innovation Consultancy
Chris McCarthy is the director of the Innovation Learning Network and of Kaiser Permanente's Innovation Consultancy. In this dual role, he leads innovation teams and connects innovators across the world to accelerate the spread of design and great ideas. His work has been featured in the Harvard Business Review (Sept 2010) and Bisognano and Kenney’s Pursuing the Triple Aim: Seven Innovators Show the Way to Better Care, Better Health, and Lower Costs (2012), as well as FastCompany, the New York Times, and many more. Some of his group’s work includes safer medication administration for patients, more robust shift changes for nurses, exploring the social space of elders, and the care experience of transgender people.
As an author, Chris collaborated with Lyle Berkowitz, MD on Innovation with Information Technologies in Healthcare (2012), and with Lisa Schilling on Schall’s Spreading Improvement Across Your Health Care Organization (2007). You can find his quirky design blog at McCarthyChris.com. He was named the 2015 H.I.T. Innovator and the 2011 Ellerbe Beckett Lecturer and is an international speaker on innovation and design.
Chris has a master’s degree in business administration from Rensselaer Polytechnic Institute / Copenhagen Business School, and a master’s degree in public health and health policy from the University of Massachusetts at Amherst. In his spare time, he obsesses about fitness, movies, and home remodels.
Healthcare investor Wende Hutton brings 23 years of experience to identifying, investing in and building companies that are changing the practice of medicine. She has facilitated bringing over a dozen medical devices and drugs to market, and currently sits on the boards of Antiva Biosciences, Chrono Therapeutics, Glooko, OncoResponse, ReVision Optics and Theraclone Sciences. Prior investments include BiPar Sciences (acquired by Sanofi-aventis), Chimerix (CMRX), Dermira (DERM), Labrys Biologics (acquired by Teva Pharmaceutical) and Transcend Medical (acquired by Alcon/Novartis). Wende was recognized among Fierce Biotech’s 2014 "Fierce 15" women in biotech and honored as one of The Most Influential Women in Bay Area Business 2015 by The San Francisco Business Times.
Wende joined Canaan in 2004, and her life sciences track record includes seven IPOs and six acquisitions. She began her venture career at Mayfield Fund in 1993, where she incubated Heartstream (HPQ) and Northstar Neuroscience (NSTR). Earlier in her career, Wende held senior operational management positions at GenPharm International and Nellcor in business development and marketing.
Wende holds an AB in human biology from Stanford University and an MBA from Harvard Business School, where she was a Baker Scholar. She is active with several community service groups including serving on the board of ReSurge International which provides reconstructive surgical care to the needy in developing countries.
Dr. Mitesh B. Rao, MD, MHS- Patient Safety Officer for Stanford Healthcare
Dr. Mitesh B. Rao, MD, MHS is the Patient Safety Officer for Stanford Healthcare where he leads patient safety for the health system. A Board Certified Emergency Medicine Physician, he also practices clinically as an Assistant Professor of Emergency Medicine at the Stanford School of Medicine.
Previously, he was trained in leadership and research skills as a Fellow in the prestigious Robert Wood Johnson Clinical Scholars Program. Subsequent to his time at Yale, he served as the Director of the Patient Safety Education Program at Northwestern Medicine. As a physician leader, he was helped implement systems-level improvements for quality and safety in institutions across the country and overseas that have had lasting effects on patient care provision. He has also led teams serving contracts with various governmental and non-profit agencies such as the Joint Commission Resources, CMS, the Canadian Patient Safety Institute, Partners Health Care, and the American College of Surgeons in multiple campaigns and initiatives to improve Patient Safety on a national level.
Dr. Rao also served as the Head of Research and Integration for the health innovation program at Northwestern. In this role, he developed an expertise in improving care provision through innovative methodologies. He spearheaded efforts to integrate innovative technologies into the health system to improve patient care in a variety of settings, including telemedicine and mHealth initiatives. Working both with innovators and researchers across the various schools of the University as well as promising startups from around the country, Dr. Rao helped guide and refine the process for vetting and integrating pilot programs to test new technologies within the clinical venue. He also serves as a mentor to multiple healthcare-focused startups and accelerator groups across the country in order to help guide the development of implementation of innovative solutions that can sustainably impact patient care provision.